Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | SLC13A5 | Q86YT5 | 7/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HMGCR | P04035 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16737228 | 1.00 | ALDH1A1 (0.58) | ALDH1A1MGAMGAASIMGAM2 | |
| SCHEMBL72953 | 0.98 | ALDH1A1 (0.60) | ALDH1A1MGAMGAASIMGAM2 | |
| SCHEMBL30384961 | 0.98 | ALDH1A1 (0.60) | ALDH1A1MGAMGAASIMGAM2 | |
| Citric Acid SCHEMBL4292973 | 0.98 | ALDH1A1 (0.60) | ALDH1A1MGAMGAASIMGAM2 | |
| Water SCHEMBL28164707 | 0.96 | ALDH1A1 (0.58) | ALDH1A1MGAMGAASIMGAM2 | |
| SCHEMBL27981114 | 0.96 | ALDH1A1 (0.58) | ALDH1A1MGAMGAASIMGAM2 | |
| Ammonia Solution, Strong SCHEMBL29179739 | 0.96 | ALDH1A1 (0.58) | ALDH1A1MGAMGAASIMGAM2 | |
| Ammonia Solution, Strong SCHEMBL9150405 | 0.96 | ALDH1A1 (0.58) | ALDH1A1MGAMGAASIMGAM2 | |
| SCHEMBL2563408 | 0.94 | ALDH1A1 (0.56) | ALDH1A1MGAMGAASIMGAM2 | |
| Hydrochloric Acid SCHEMBL7039336 | 0.94 | ALDH1A1 (0.56) | ALDH1A1MGAMGAASIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117258040-A | Preparation method of 3D printing cerium hydroxyapatite bone repair stent material | 西北大学 | 2023-12-22 | — | — | CN | claimed |
| CN-105385680-B | For the reagent that DNA and RNA is extracted simultaneously, extracting method and purposes | 天津脉络生物科技有限公司 | 2019-01-25 | — | — | CN | claimed |
| CN-106735295-B | A kind of two-dimensional layer Au nanometer sheet material and preparation method thereof | 中南大学 | 2018-11-23 | — | — | CN | claimed |
| CN-105728742-B | The preparation method of Au nano materials/Au metal oxide nano composite materials | 陈羽 | 2018-02-16 | — | — | CN | claimed |
| CN-106735295-A | A kind of two-dimensional layer Au nanometer sheet materials and preparation method thereof | 中南大学 | 2017-05-31 | — | — | CN | claimed |
| CN-105728742-A | Preparation method for Au nanometer material/Au-metallic oxide nano-composite material | 陈羽 | 2016-07-06 | — | — | CN | claimed |
| CN-103893620-B | Chinese medicinal composition for preventing and treating diabetes and preparation method thereof | LI ZHENGCHAO | 2015-04-08 | — | — | CN | claimed |
| CN-103893620-A | Chinese medicinal composition for preventing and treating diabetes and preparation method thereof | LI ZHENGCHAO | 2014-07-02 | — | — | CN | claimed |
| CN-103146668-A | Preparation process of lumbrokinase dry powder | TIANJIN JIAWO TECHNOLOGY CO LTD | 2013-06-12 | — | — | CN | claimed |
| CN-117258040-A | Preparation method of 3D printing cerium hydroxyapatite bone repair stent material | 西北大学 | 2023-12-22 | — | — | CN | disclosed |
| CN-113546171-A | Phototherapy nano antibacterial material and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2021-10-26 | — | — | CN | disclosed |
| CN-110797581-B | Porous carbon material composite gel polymer electrolyte based on ultrahigh specific surface area and preparation method and application thereof | 广州大学 | 2020-12-08 | — | — | CN | disclosed |
| CN-110797581-A | Porous carbon material composite gel polymer electrolyte based on ultrahigh specific surface area and preparation method and application thereof | 广州大学 | 2020-02-14 | — | — | CN | disclosed |
| CN-110292574-A | A kind of anti-bowelcancer medicine composition and its application | 江苏红豆杉药业有限公司 | 2019-10-01 | — | — | CN | disclosed |
| US-20120022088-A1 | PHARMACEUTICAL COMBINATION OF 5-FLUOROURACIL AND DERIVATE OF 1,4-DIHYDROPYRIDINE AND ITS USE IN THE TREATMENT OF CANCER | JSC GRINDEKS (LV) | 2012-01-26 | — | — | US | disclosed |
| EP-2406218-A1 | Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer | Grindeks, A Joint Stock Company (LV) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010103067-A1 | PHARMACEUTICAL COMBINATION OF 5-FLUOROURACIL AND DERIVATE OF 1,4-DIHYDROPYRIDINE AND ITS USE IN THE TREATMENT OF CANCER | GRINDEKS, A JOINT STOCK COMPANY (LV) | 2010-09-16 | — | — | WO | disclosed |
| EP-2228365-A1 | Pharmaceutical combination of 5-fluorouracil and derivative of 1,4-dihydropyridine and its use in the treatment of cancer | Grindeks, a joint stock company (LV) | 2010-09-15 | — | — | EP | disclosed |
| CN-1303086-C | Compound of dual functional esterified prodrug of Cefetamet, and oral preparation | ZHU XIAOMAO (CN) | 2007-03-07 | — | — | CN | disclosed |
| CN-1687076-A | Compound of dual functional esterified prodrug of Cefetamet, and oral preparation | ZHU XIAOMAO (CN) | 2005-10-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022088-A1 | PHARMACEUTICAL COMBINATION OF 5-FLUOROURACIL AND DERIVATE OF 1,4-DIHYDROPYRIDINE AND ITS USE IN THE TREATMENT OF CANCER | DPYD, DHFR, FOLR1 | ALDH1A1 63/4885MGAM 1973/4885GAA 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.